ArticleBasic and clinical andrology2025
Density gradient centrifugation specifically improves sperm motility in hyperuricemia: evidence from intrauterine insemination cycles - retrospective cohort study.
Article in Basic and clinical andrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHyperuricemia (HUA) impairs sperm function via oxidative stress and metabolic dysregulation. This retrospective cohort study aimed to investigate the therapeutic effect of density gradient centrifugation (DGC) on HUA-associated sperm dysfunction.
resultsA total of 490 couples undergoing their first intrauterine insemination (IUI) were stratified into the HUA group (200 cycles) and control group (290 cycles) based on male serum uric acid levels. At baseline, the percentage of progressively motile sperm (PR%) in the HUA group was significantly lower than that in the control group (39.55% ± 11.29% vs. 41.76% ± 11.89%, P = 0.040). Following DGC processing, PR% in both groups exceeded 90% with no significant intergroup difference; however, the increase in PR% (ΔPR%) was significantly greater in the HUA group (52.34% ± 10.62% vs. 50.29% ± 11.02%, P = 0.040). No significant difference was observed in the clinical pregnancy rate between the two groups (11.0% vs. 13.4%, P = 0.230).
conclusionsDGC specifically improves sperm motility in patients with HUA. While direct measurement of mechanistic markers (e.g., oxidative stress, metabolic factors) was not performed in this study, this motility-improving effect may correlate with DGC's known capacity to scavenge reactive oxygen species and optimize energy supply-an inference supported by prior mechanistic studies. However, improving sperm motility alone is insufficient to significantly enhance clinical pregnancy rates. These findings provide insights to optimize semen preparation strategies in HUA-associated male infertility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.